About Casper Pharma
Casper Pharma is a company based in East Brunswick (United States) founded in 2016 was acquired by Suven Pharmaceuticals in April 2022. It operates as a Direct-to-Consumer (D2C) and B2B2C. Casper Pharma offers products and services including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
- Headquarter East Brunswick, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$1.24 M (USD)526as on Mar 31, 2022
-
Net Profit
-$1.96 M (USD)-117as on Mar 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Suven Pharmaceuticals
(Apr 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Casper Pharma
Casper Pharma offers a comprehensive portfolio of products and services, including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
Medication developed for cardiovascular health management and treatment.
Therapies provided for gastrointestinal conditions and patient care.
Medications offered for urological issues and health improvement.
Solutions created for pain management and patient relief.
Treatments designed for ophthalmic conditions and vision care.
Funding Insights of Casper Pharma
Detailed funding history for Casper Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Casper Pharma
Casper Pharma has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract manufacturing and development of APIs and formulations are provided.
|
Locked | Locked | Locked |
Investor details for Casper Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Casper Pharma
Investment portfolio details for Casper Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Casper Pharma
Detailed financials for Casper Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Casper Pharma Comparisons
Peer comparison for Casper Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Casper Pharma
Detailed competitors of Casper Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Casper Pharma
Complete news archive for Casper Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Casper Pharma
Casper Pharma was founded in 2016.
Casper Pharma is headquartered in East Brunswick, United States. It is registered at East Brunswick, New Jersey, United States.
Annual revenue of Casper Pharma is $1.24M as on Mar 31, 2022.
Casper Pharma is engaged in the development, acquisition, and commercialization of specialty pharmaceuticals aimed at improving patient lives. The company operates within cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets. Solutions are provided through a global network, leveraging innovation and technology to address unmet medical needs. A commitment to high-quality, cost-effective therapies is maintained to serve healthcare communities and enhance patient outcomes.
Casper Pharma offers Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
Casper Pharma has 1 investor. Key investors include Suven Pharma.